Western blot and qPCR analyses further confirmed the significant elevation of Gfap expression in the PDPN group compared to the Control and DM groups (Figure 6D,E), indicating enhanced SGC proliferation or activation in response to diabetic neuropathy. This evidence concerns the gene GFAP and diabetes mellitus.